Novobiocin sodium

Novobiocin sodium is an antibiotic mainly used in laboratory research rather than clinical treatment. It works by inhibiting bacterial DNA gyrase, an enzyme essential for DNA replication, making it effective against certain Gram-positive bacteria. In microbiology, it is commonly used to differentiate coagulase-negative staphylococci, especially in identifying Staphylococcus saprophyticus, that is resistant to novobiocin, from Staphylococcus epidermidis, that is sensitive. Its clinical use is limited due to toxicity and the availability of safer alternatives. It is grouped under the following drug class(es): PARP Inhibitors. The directory classifies it as a discontinued API with a fermentation-derived source/manufacturing origin. Other names for this substance include Albamycin, Albadry, Cathomycin and Cathomycin sodium. Its PubChem CID is 23663939.

CAS No 1476-53-5
Molecular Formula C31H35N2NaO11
Molecular Weight 634.6 g/mol
Synonyms sodium;7-[(2R,3R,4S,5R)-4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-4-olate

Frequently Asked Questions